abstract |
This invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R 1 , R 2 ,R 3 , R 4 , R 5 , R 6 , R 7 , k, m, n, p, q, r and s are each as described herein, and compositions containing such compounds, and the use of such compounds in the treatment of a condition mediated by CB2 receptor activity. |